12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device

Status Completed

Clinical Trial Summary

This is an open-label, multicenter study designed to assess the safety of intranasal administration of 400 μg of fluticasone propionate twice a day delivered by the OptiNose device in subjects with chronic sinusitis with or without nasal polyps. The study consists of an up-to-7-day pretreatment phase followed a 12-month open-label treatment phase. The duration of each subject's participation is approximately 53 weeks.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01623310
Study type	Interventional
Source	Optinose US Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	September 2013
Completion date	October 2015

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT02071667` - Association of Periostin Levels and Chronic Sinusitis	N/A
Completed	`NCT02024659` - Effects and Safety of Budesonide Inhalation Suspension Via Transnasal Nebulization in Nasal Polyps	Phase 2/Phase 3
Completed	`NCT00215787` - Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease	N/A
Completed	`NCT04996576` - Infrazygomatic Versus Intranasal Injection Sphinopalatine Ganglion Blockade Effect on Surgical Field in FESS	N/A
Recruiting	`NCT03963648` - NO Measurements in Screening for Asthma and OSA, in Patients With CRSwNP	N/A
Recruiting	`NCT05094570` - Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP	Phase 4
Recruiting	`NCT05009758` - Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps	N/A
Completed	`NCT00731185` - Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)	Phase 3
Active, not recruiting	`NCT03943121` - The Effects of Steroid-eluting Stent Implant for the Treatment of Eosinophilic Chronic Rhinosinusitis With Nasal Polyps	N/A
Active, not recruiting	`NCT03704415` - Aggravated Airway Inflammation: Research on Genomics and Optimal Operative Treatment (AirGOs Operative)	N/A
Not yet recruiting	`NCT06070311` - Wound Healing After Endoscopic Sinus Surgery	N/A
Completed	`NCT02879929` - Development and Validity of the DyNaChron Questionnaire for Chronic Nasal Dysfunction	N/A
Recruiting	`NCT05672030` - Role of IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP
Suspended	`NCT04261582` - Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)
Recruiting	`NCT05063981` - Treatment With Mepolizumab on Patients With Severe Refractory Eosinophilic Asthma With or Without CRSwNP.
Completed	`NCT05180357` - RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.
Completed	`NCT00788463` - A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps	Phase 2
Completed	`NCT01198912` - Influence of Oral Doxycycline on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With and Without Nasal Polyposis: a Double-blind Randomized Placebo-controlled Trial	Phase 2
Completed	`NCT03280537` - A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps	Phase 3
Completed	`NCT00440219` - The Effect of Preoperative Oral Prednisone on the Operative Field During Nasal Polypectomy.	Phase 3